Neurovirulence of Type 1 Polioviruses Isolated from Sewage in Japan

Overview

Journal Appl Environ Microbiol

Specialties Environmental Health
Microbiology

Date 2002 Jan 5

PMID 11772619

Citations 4

Authors

Hitoshi Horie

Hiromu Yoshida

Kumiko Matsuura

Miwako Miyazawa

Yoshihiro Ota

Takashi Nakayama

Yutaka Doi

So Hashizume

Affiliations

Soon will be listed here.

Abstract

Sixteen type 1 poliovirus strains were isolated from a sewage disposal plant located downstream of the Oyabe River in Japan between October 1993 and September 1995. The isolates were intratypically differentiated as vaccine-derived strains. Neutralizing antigenicity analysis with monoclonal antibodies and estimation of neurovirulence by mutant analysis by PCR and restriction enzyme cleavage (MAPREC) were performed for 13 type 1 strains of these isolates. The isolates were classified into three groups. Group I (five strains) had a variant type of antigenicity and neurovirulent phenotype. Group II (four strains) had the vaccine type of antigenicity and neurovirulent phenotype. Group III (four strains) had the vaccine type of antigenicity and an attenuated phenotype. Furthermore, it was demonstrated that the virulent isolates were neutralized by human sera obtained after oral poliomyelitis vaccine (OPV) administration, and the sera of rats immunized with inactivated poliovirus vaccine. Although vaccination was effective against virulent polioviruses, virulent viruses will continue to exist in the environment as long as OPV is in use.

Citing Articles

Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.

Tebbens R, Zimmermann M, Pallansch M, Thompson K Food Environ Virol. 2017; 9(4):361-382.

PMID: 28687986 PMC: 7879701. DOI: 10.1007/s12560-017-9314-4.

Impact of xynthia tempest on viral contamination of shellfish.

Grodzki M, Ollivier J, Le Saux J, Piquet J, Noyer M, Le Guyader F Appl Environ Microbiol. 2012; 78(9):3508-11.

PMID: 22344664 PMC: 3346494. DOI: 10.1128/AEM.07604-11.

A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region.

Arita M, Zhu S, Yoshida H, Yoneyama T, Miyamura T, Shimizu H J Virol. 2005; 79(20):12650-7.

PMID: 16188967 PMC: 1235834. DOI: 10.1128/JVI.79.20.12650-12657.2005.

Construction of a cloning system for the mass production of a virus-binding protein specific for poliovirus type 1.

Sano D, Omura T Appl Environ Microbiol. 2005; 71(5):2608-15.

PMID: 15870352 PMC: 1087535. DOI: 10.1128/AEM.71.5.2608-2615.2005.

References

Chumakov K, Norwood L, Parker M, Dragunsky E, Ran Y, Levenbook I . RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence. J Virol. 1992; 66(2):966-70. PMC: 240798. DOI: 10.1128/JVI.66.2.966-970.1992. View

Mulders M, Reimerink J, Stenvik M, Alaeddinoglu I, van der Avoort H, Hovi T . A Sabin vaccine-derived field isolate of poliovirus type 1 displaying aberrant phenotypic and genetic features, including a deletion in antigenic site 1. J Gen Virol. 1999; 80 ( Pt 4):907-916. DOI: 10.1099/0022-1317-80-4-907. View

Shulman L, Manor Y, Handsher R, Delpeyroux F, McDONOUGH M, Halmut T . Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol. 2000; 38(10):3729-34. PMC: 87465. DOI: 10.1128/JCM.38.10.3729-3734.2000. View

Matsuura K, Ishikura M, Yoshida H, Nakayama T, Hasegawa S, Ando S . Assessment of poliovirus eradication in Japan: genomic analysis of polioviruses isolated from river water and sewage in toyama prefecture. Appl Environ Microbiol. 2000; 66(11):5087-91. PMC: 92424. DOI: 10.1128/AEM.66.11.5087-5091.2000. View

Yoshida H, Horie H, Matsuura K, Miyamura T . Characterisation of vaccine-derived polioviruses isolated from sewage and river water in Japan. Lancet. 2000; 356(9240):1461-3. DOI: 10.1016/S0140-6736(00)02868-3. View

. Outbreak of poliomyelitis--Dominican Republic and Haiti, 2000. MMWR Morb Mortal Wkly Rep. 2000; 49(48):1094, 1103. View

. Circulation of a type 2 vaccine-derived poliovirus--Egypt, 1982-1993. MMWR Morb Mortal Wkly Rep. 2001; 50(3):41-2, 51. View

Horie H, Miyazawa M, Ota Y, Wakabayashi K, Yoshida H, Doi Y . Analysis of the accumulation of mutants in Sabin attenuated polio vaccine viruses passaged in Vero cells. Vaccine. 2001; 19(11-12):1456-9. DOI: 10.1016/s0264-410x(00)00350-9. View

Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S . Rapid evolution of RNA genomes. Science. 1982; 215(4540):1577-85. DOI: 10.1126/science.7041255. View

10.

Evans D, Dunn G, Minor P, Schild G, Cann A, Stanway G . Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature. 1985; 314(6011):548-50. DOI: 10.1038/314548a0. View

11.

Nkowane B, Wassilak S, Orenstein W, Bart K, Schonberger L, Hinman A . Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA. 1987; 257(10):1335-40. View

12.

Ward C, Stokes M, Flanegan J . Direct measurement of the poliovirus RNA polymerase error frequency in vitro. J Virol. 1988; 62(2):558-62. PMC: 250568. DOI: 10.1128/JVI.62.2.558-562.1988. View

13.

Poyry T, Stenvik M, Hovi T . Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland. Appl Environ Microbiol. 1988; 54(2):371-4. PMC: 202459. DOI: 10.1128/aem.54.2.371-374.1988. View

14.

Kawamura N, Kohara M, Abe S, Komatsu T, Tago K, Arita M . Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol. 1989; 63(3):1302-9. PMC: 247827. DOI: 10.1128/JVI.63.3.1302-1309.1989. View

15.

Westrop G, Wareham K, Evans D, Dunn G, Minor P, MAGRATH D . Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol. 1989; 63(3):1338-44. PMC: 247831. DOI: 10.1128/JVI.63.3.1338-1344.1989. View

16.

Skinner M, Racaniello V, Dunn G, Cooper J, Minor P, Almond J . New model for the secondary structure of the 5' non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J Mol Biol. 1989; 207(2):379-92. DOI: 10.1016/0022-2836(89)90261-1. View

17.

Pollard S, Dunn G, Cammack N, Minor P, Almond J . Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine. J Virol. 1989; 63(11):4949-51. PMC: 251143. DOI: 10.1128/JVI.63.11.4949-4951.1989. View

18.

Benyesh-Melnick M, Melnick J, Rawls W, WIMBERLY I, Oro J, Ben-Porath E . Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter. Am J Epidemiol. 1967; 86(1):112-36. DOI: 10.1093/oxfordjournals.aje.a120717. View

19.

Chumakov K, POWERS L, Noonan K, Roninson I, Levenbook I . Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci U S A. 1991; 88(1):199-203. PMC: 50777. DOI: 10.1073/pnas.88.1.199. View

20.

Dunn G, Begg N, Cammack N, Minor P . Virus excretion and mutation by infants following primary vaccination with live oral poliovaccine from two sources. J Med Virol. 1990; 32(2):92-5. DOI: 10.1002/jmv.1890320205. View